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Over-diagnosis of malaria by microscopy in the
Kilombero Valley, Southern Tanzania: an
evaluation of the utility and cost-effectiveness of
rapid diagnostic tests
Kelly Harchut1*, Claire Standley1, Andrew Dobson1, Belia Klaassen2, Clotilde Rambaud-Althaus3,
Fabrice Althaus3 and Katarzyna Nowak1
Abstract
Background: Early and accurate diagnosis of febrile patients is essential to treat uncomplicated malaria cases
properly, prevent severe malaria, and avert unnecessary anti-malarial treatments. Improper use of anti-malarials
increases the risk of adverse drug reaction and the evolution of drug/parasite resistance. While microscopy is the
most common form of malaria diagnosis, concerns over its accuracy have prompted the incorporation of malaria
rapid diagnostic tests (RDTs) into many national malaria control programmes.
Methods: Over a three-month period, a direct comparison between microscopy and RDTs was made in a rural,
private dispensary in the Kilombero Valley, Morogoro District, southern Tanzania, with the aim of estimating the
extent of malaria over-diagnosis and over-treatment with anti-malarials. The study cohort was made up of patients
referred by the dispensary’s clinician for malaria testing. One hundred percent of patients approached agreed to
participate in this study and were then tested using both microscopy and RDTs. Using the results from the
comparison of the two tests at this dispensary, the potential cost effectiveness of introducing RDTs to a
neighbouring public health centre was estimated on the basis of this centre’s past malaria records spanning
December 2007 to August 2011.
Results: At the private dispensary, the apparent prevalence of malaria was 78% based on microscopy whereas the
true prevalence, calculated using RDTs as the gold standard, was estimated at 14%. This discrepancy indicates that
when using microscopy as the sole diagnostic test, malaria is being over-diagnosed by approximately a factor of
five in this setting. At the public clinic, apparent malaria prevalence based on microscopy was 74%. If similar rates
of over-diagnosis are assumed, 5,285 patients of the 6,769 patients positively diagnosed with malaria using
microscopy were likely given unnecessary anti-malarials, and their true cause of illness was not addressed. The
introduction of RDTs to the public clinic would be highly cost-efficient, with an estimated net saving of over 96
USD/month.
Conclusions: Compared with RDTs, microscopy led to almost four out of five patients being over-diagnosed with
malaria in this rural part of Tanzania. A policy that encompasses both the private and public sectors of health care
is needed to ensure quality diagnostic testing for febrile patients. With estimated prevalence at 14%, RDT
introduction is recommended given WHO findings that RDTs are predicted to be cost-effective in prevalence areas
of less than 20%. The use of RDTs in malaria diagnosis would not only reduce government spending but would
prove beneficial to ensuring appropriate care and treatment of febrile illness.
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Background
Malaria is currently endemic in 106 countries where it
leads to an estimated 216 million cases per year and
655,000 deaths, the majority of which are in sub-Saharan
Africa [1]. Recent large-scale efforts are underway in
many malaria-endemic regions to reduce the morbidity
and mortality associated with malaria; improving access
to effective treatment is a significant part of these initia-
tives [2]. As a result of these efforts, malaria cases and
malaria-related deaths in mainland Tanzania have been
reduced by up to 50% in the past decade [3].
The extensive deployment of anti-malarial drugs has
provided strong selective pressure on human malaria
parasites to evolve mechanisms of resistance [4]. This is
substantiated in the rapid spread of Plasmodium falcip-
arum resistance to chloroquine [5], and the efforts made
to limit drug-resistant malaria through the use of
artemisinin-based combination therapy (ACT) over arte-
misinin monotherapy [6,7]. However, other factors also
contribute to resistance, and accurate diagnosis of mal-
aria can help ensure that ACT is not over-prescribed.
Based on the presumption that most fever cases in en-
demic areas were the result of malaria, WHO once
recommended presumptive treatment for malaria, par-
ticularly for children under the age of five [1]. However,
when unnecessary treatments are dosed or taken im-
properly, particularly in regions of high malaria endem-
icity where many people suffer from frequent subclinical
malaria infections, resistance can rapidly emerge. Moreover,
indiscriminate treatment of most febrile illness, such as
malaria, results in the true cause of illness failing to be iden-
tified if the patient is in fact non-malarial. Documenting the
extent to which ACT is used unnecessarily is thus crucial
to curbing drug resistance and improving patient care.
In health facilities with laboratories, simple light mi-
croscopy examinations of Giemsa-stained blood films
are the most widely practiced method for malaria diag-
nosis [8]. Advantages of microscopy include differenti-
ation between species, quantification of parasite density,
and ability to distinguish clinically important asexual
parasite stages from gametocytes – the sexual stage of
the parasite, which may persist without causing symp-
toms [9]. Despite these advantages, in many parts of
sub-Saharan Africa, routine microscopy is known to be
of low quality due to poor training, low skill level of la-
boratory staff, poor infrastructure, inadequacy of equip-
ment and reagents, and unreliable electricity [8,10].
These challenges may result in laboratory technicians’
over-diagnosis of malaria, which may be the result from
previous WHO recommendations based on the assump-
tion that it is safer to treat non-malarial patients with
anti-malarials than missing a true case of malaria [11].
Therefore, even though microscopy can yield accurate
and specific malaria diagnosis, in environments with
limited resources and funding, such as in sub-Saharan
Africa, its use can be associated with routine over-
diagnosis of malaria [12].
Malaria rapid diagnostic tests (RDTs), which require
minimal training, have begun to be used for routine mal-
aria testing in a number of African countries and have
proved to have high sensitivity and specificity [8,13].
Requiring only a drop of blood, RDTs detect antigens
specific to Plasmodium species. Some RDTs can differ-
entiate between malaria species while others test only
for antigens specific to P. falciparum.
According to WHO, approximately 40% of malaria pa-
tients worldwide seek treatment for malaria in the pri-
vate sector, which includes regulated health facilities,
pharmacies and other drug outlets [14]. As such, the
Affordable Medicines Facility for malaria (AMFm),
a “factory-gated” subsidy for ACT launched in 2010,
aims to increase the availability of effective, artemisinin-
combination anti-malarials in both the public and pri-
vate sectors [15]. AMFm increases the availability of
ACTs, in part because a subsidy is provided. However,
this program has very little focus on accurate diagnosis
of patients with malaria. It is therefore important that
both the public and private sectors are considered in re-
search investigating the implications of diagnostic tools
on public health outcomes.
Within the setting of the Kilombero Valley of southern
Tanzania, a malaria hotspot, the aim of this study was to
conduct a direct comparison between microscopy and
RDTs at a private clinic in order to estimate the percent-
age of the population seeking anti-malarial treatment in
the private sector that is actually infected with malaria.
Then, using results from this comparison, this study
aimed to estimate the cost-effectiveness of RDTs for
malaria diagnosis in this rural area.
Methods
Study site
Malaria case data were collected for patients at two health
facilities in Kilombero District, Morogoro, southern
Tanzania. These facilities are a private dispensary in the
village of Mwaya (S 07°51’17.4”, E 036°53’39.9”) and a
government-owned public health centre in the village of
Mang’ula (S 07°50’19.9”, E 036°53’32.8”). The two villages
are 1.8 km apart, and adjacent to the Udzungwa Moun-
tains National Park (Figure 1). Plasmodium falciparum is
the only malaria species reported in this region [1].
According to the 2002 Tanzania Housing and Popula-
tion Census, Mwaya has a population of 9,841 people
and Mang’ula a population of 12,083 people [16]. The
Kilombero Valley’s population is currently estimated at
321,611 people.
According to the National Park’s weather station, mean
annual rainfall in this area ranges from 1,200-1,800 mm
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and follows a unimodal pattern falling from December to
April; however, variability in this pattern has been ob-
served in recent years (pers obs 2008-present).
Study design
A direct comparison between RDTs and microscopy was
made at the private dispensary from June to mid-August
2011. The results were used to estimate retroactively the
levels of over-diagnosis for much of the previous three
and a half years at the nearby public health centre, which
had more extensive data on monthly malaria rates, saw
more patients and had a wider demographic of patients.
Study participants
At the private dispensary, eligible patients included any
patient for whom the clinician judged a malaria diagnos-
tic test necessary, based on case history and presenting
symptoms. Between June and August 2011, 400 patients
participated in this study and were tested with both mi-
croscopy and RDT.
The study population at the public health centre was
made up of all patients who were tested for malaria
during the time period for which malaria records were
available, i e, from December 2007 until August 2011,
excluding April 2008, September 2008 to March 2009,
February 2010, and August 2010 to October 2010.
Figure 1 Map of study region indicating location of the two health facilities.
Harchut et al. Malaria Journal 2013, 12:159 Page 3 of 9
http://www.malariajournal.com/content/12/1/159
Because of limited availability of malaria records at the
public health centre, data during these months were
never collected. All 9,175 patients tested with micros-
copy during this period were included in the retrospect-
ive study.
Study protocol
At the private dispensary, results of RDTs (ICT Malaria
Combo Cassette, ICT Diagnostics, Cape Town, South
Africa) and blood slide microscopy were directly com-
pared. ICT Malaria Combo Cassette Test is a rapid,
in vitro diagnostic test for the detection of circulating P.
falciparum antigens (HRPII antigen); an antigen that is
common to all five species of human malaria is aldolase
antigen [17]. According to WHO RDT Product Testing
(Round 1) results from 2008, the detection rate of the
ICT Malaria Combo Cassette Test for identifying P. fal-
ciparum is 86% at low parasite density (<200 parasites/
μl) and 100% at a higher parasitaemia (2,000-5,000 para-
sites/μl). This test is reported to have a Plasmodium
vivax detection rate of 0% at low parasite density (<200
parasites/μl) and 95% at a higher parasitaemia (2,000-
5,000 parasites/μl) [17]. Given the high sensitivity and
specificity of RDTs, and because of the known inaccur-
acy of routine microscopy in many rural clinics, the
RDT was considered the gold standard for the purposes
of this study.
Each patient tested at the private dispensary com-
pleted a short questionnaire providing sociodemographic
characteristics, medical history, information on malaria
prevention measures, and information on the frequency
and types of anti-malarial treatments used (see
Additional file 1). After testing with both microscopy
and RDTs, patients returned to the clinician with both
laboratory results and a final clinical diagnosis was made
by the attending doctor and recorded by the study team.
At the public health centre, RDTs had been introduced
by another research project as the sole diagnostic
method for malaria in March 2011, in accordance with
national policy of scaling up of RDTs at the country
level. Prior to this introduction, microscopy was the sole
diagnostic method. Because this clinic had ceased to use
microscopy at the time of this study, the clinic did not
at any point use RDTs and microscopy simultaneously.
Therefore, given potential seasonal fluctuations in mal-
aria burden, it was not possible to compare RDT results
to microscopy results. Instead, a side-by-side compari-
son was done between the data collected at the private
dispensary and the data collected previously at the pub-
lic health centre. Hard copies of patient malaria records
collected before and after RDT introduction were digi-
tized to estimate the potential overuse of anti-malarials
following diagnosis using microscopy. These records in-
cluded patient age, sex, address, and the blood slide
results (for patients tested prior to March 2011) or RDT
results (for patients testing from March 2011 onwards).
Analysis of cost-effectiveness
At the public health centre, regardless of the type of
diagnostic test used, the cost to the patient for malaria
testing was 0.25 USD (500 Tanzanian Shillings, at 2011
conversion rates). The cost to the government of using
RDT kits was 1.44 USD, adjusted for the price of the
ICT Combo Cassette test (0.52 USD/test) (adapted from
[18]); the cost of using microscopy was estimated at 0.59
USD [18]. These costs to the government include labour
costs associated with each test and were used to calcu-
late the average monthly costs spent by the government
on malaria diagnostics. The average number of each
diagnostic tests preformed was also calculated. Based on
observations at the clinic, it was assumed that all pa-
tients diagnosed with malaria using either an RDT or
microscopy received and used anti-malarial drugs. In
conjunction with the data collected from the direct com-
parison at the private dispensary, it was possible to cal-
culate: 1) an estimate of government expenditure on
unnecessary anti-malarial treatments; 2) the cost to the
government of providing subsidized RDTs; and, 3) the
net savings resulting from accurate malaria diagnosis.
Statistical analyses
All analyses were undertaken using R version 2.13.1 [19].
Only patients with complete data including age, sex, and
malaria test results were included in the analysis. The
breakdown of age and sex was tabulated for the data
from each of the two health facilities. A binomial exact
test was used to determine the rates of positive and
negative microscopy results, and the rates of positive
and negative RDTs at both facilities. Using the epi.tools
package in R, the specificity, sensitivity, negative predict-
ive values, positive predictive values, 95% confidence in-
tervals, and the apparent and estimated over-treatment
with anti-malarials was calculated for the private clinic.
RDTs were considered the gold standard for this ana-
lysis. Using the retrospective design, the extent of over-
treatment with anti-malarials and the cost-effectiveness
of the introduction of RDTs were calculated for the pub-
lic health centre. Because a large proportion of patients
using clinics were children, a non-parametric regression
was used in which subsequent age categories were
double the size of the previous age category in order to
allow a better representation of prevalence of malaria at
a young age (one month, three months, six months, one
year, two years, four years, eight years, 16 years, 32 years,
64 years, and 64+ years). Association between malaria
prevalence and variables such as age and rainfall were
tested with Pearson’s product–moment correlation.
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Ethical considerations
Prior to participating in this study, each patient provided in-
formed written consent. Ethical approval for this study was
obtained from the Tanzania National Institute for Medical
Research (NIMR/HQ/R.8a/Vol. IX/1165) and the Princeton
University Institutional Review Board (IRB # 5374).
Results
Study population
At the private dispensary, 195 children and 205 adults
(400 total; 47% males and 53% females, mean age =
32.6 years, median age = 32 years, SD = 23.04 years) were
tested for malaria using both microscopy and RDTs. Of
these, 317 patients (79%) tested positive with microscopy
and 57 (14%) tested positive with RDTs (Table 1).
At the public clinic, data were acquired from 10,949
malaria cases (6,797 children and 4,152 adults, 36%
males and 64% females). The mean age of patients test-
ing for malaria at the public clinic was 15.5 years, me-
dian age was 10 years, and the standard deviation was
16.54 years. These patients were tested for malaria using
either a microscopy test or an RDT (post March 2011).
Out of 9,175 patients, 6,769 (74%) tested positive with
microscopy and 88 out of 1,774 patients (5%) patients
tested positive with RDTs (Table 1).
Table 2 shows the sensitivity, specificity, positive pre-
dictive values (PPV), and negative predictive values
(NPV) of microscopy at the private dispensary using
RDTs as the gold standard. Using the PPV and NPVs,
the percentage of patients visiting the private clinic with
malaria could be calculated demonstrating an apparent
malaria prevalence of 78% and true malaria prevalence
of 14% (Figure 2). This indicates that when using mi-
croscopy as the sole diagnostic test, malaria is being
over-diagnosed by 64%. All (100%) patients at the private
clinic reported regular usage of bed nets.
Malaria prevalence and age
Apparent malaria prevalence was higher when using mi-
croscopy than when using RDTs in both the private dis-
pensary and public health centre and for each age
category (Figure 3). There was no association between
apparent or true prevalence and age of patient at either
the private dispensary or the public health centre (Pri-
vate: t = −0.92, df = 9, p = 0.38, r = −0.29; Public: t = 0.61,
df = 9, p = 0.55, r = −0.20).
Anti-malarial treatment at the private clinic
Of the anti-malarial medications used by patients in the
private dispensary, artemether-lumefantrine (ALu) was
the most frequently used medication (81%). At the time
of this study, ALu cost 0.31 USD for patients zero to
three years old, 0.63 USD for patients four to eight years
old, 0.94 USD for patients nine to 14 years old, and 1.26
USD for patients 15 years and older. Metakelfin, or
sulphadoxine-pyrimethamine combination therapy, was
the second most frequently used medication (13%; 1.89
USD). Finally, quinine was the least frequently used
medication (5%, 3.78 USD) (Table 3). As a result of
AFMm, the cost per treatment for ALu to first-line
buyers is 0.33 USD with a co-payment by the Global
Fund of 0.32 USD per treatment [20].
Table 1 Breakdown of the sample population in the
public and private facilities including sample size, age,
microscopy and RDT results
Mang’ula (Public) Mwaya (Private)
Sample Size (N) 11049 400
Age
Median age 10 (SD = 16.54) 32 (SD = 23.04)
Children 6797 195
Adult 4152 205
Sex
Male 3963 (36%) 188 (47%)
Female 6986 (64%) 212 (53%)
Microscopy n = 9175 n = 400
Positive 6769 317
Negative 2406 83
Prevalence 74% 79%
RDT n = 1774 n = 400
Positive 88 57
Negative 1686 343
Prevalence 5% 14%
Table 2 Sensitivity, specificity, positive predictive values
(PPV), and negative predictive values (NPV) of
microscopy by age category, as well as the overall
sensitivity, specificity, PPVs and NPVs using RDTs as the
gold standard
Age Sensitivity Specificity PPV NPV
(95% CI) (95% CI) (95% CI) (95% CI)
Less than 1 1.00 0.27 0.11 1.00
(0.01 – 1.00) (0.06 - 0.61) (0.00-0.48) (0.19 – 1.00)
1-5 1.00 0.19 0.14 1.00
(0.55 – 1.00) (0.11 -0.31) (0.07 - 0.25) (0.66 – 1.00)
6-18 0.88 0.24 0.17 0.92
(0.64 - 0.99) (0.16- 0.34) (0.10-0.27) (0.74 -0.99)
19+ 1.00 0.27 0.20 1.00
(0.82 – 1.00) (0.20-0.35) (0.14 -0.28) (0.87 – 1.00
Overall 0.96 0.25 0.18 0.98
(0.87-1.00) (0.20 - 0.30) (0.14- 0.22) (0.92 – 1.00)
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Analysis of cost-effectiveness
At the public health centre, the average monthly costs
(including labour) of performing diagnostic tests with mi-
croscopy were estimated at an average of 208 USD spent
by the government on 352 microscopy tests per month
from December 2007 to February 2011 (excluding April
2008, September 2008 to March 2009, February 2010, and
August 2010 to October 2010). Conversely, an average of
425 USD was spent by the government clinic on 295 RDTs
per month during the six-month period of March 2011 to
August 2011.
For the purpose of the cost analysis, the mean age of pa-
tients (15.5 years) testing for malaria at the public health
centre was used to determine the average price spent on
ALu by patients. This amounted to an average of 328
USD spent on ALu per month since December 2007 when
microscopy was used to diagnose malaria, and an average
of 15 USD/month spent on ALu since the introduction of
RDTs in March 2011. Because the true prevalence of
malaria appears to be only 14% in this area, 5,485 of the
6,769 patients testing positive with microscopy received
malaria medication for febrile illness caused by reasons
other than malaria, resulting in the over-prescription of
anti-malarials, improper treatment of these patients, and
an extra 265 USD/month spent on anti-malarials. Thus,
even with the added costs of RDTs, the introduction of
RDTs resulted in a net savings of 96 USD/month. Using
microscopy, there were two cases of false negatives, but
overall, the number of false negatives was negligible com-
pared to the number of false positives.
Discussion
There was a marked difference between the number of
positive malaria cases diagnosed with microscopy tests
and with RDTs. This difference suggests that malaria is
being over-diagnosed by 64% with microscopy in this
rural region of Tanzania. This study was not random-
controlled; therefore, some sample bias was inherent
given that only patients living in the vicinity of these two
clinics, and sick enough to seek medical treatment, were
included in the study. Additionally, cautions are needed
when extrapolating results of retrospective data as poten-
tial differences in the ecology and epidemiology of malaria
may exist between the two neighbouring villages, although
given their close proximity, this is highly unlikely. For
example, no association was found between malaria preva-
lence and rainfall, at either clinic [Pearson’s test].
Additionally, while the prescription practices of health
care workers after a positive and negative RDT result
could certainly affect the assumed cost-effectiveness of the
introduction of RDTs, this study did not collect these data.
Future studies should investigate the effects of these prac-
tices on the deployment of RDTs.
The introduction of RDTs at the public clinic proved
to be cost-effective, resulting in a net saving of 96 USD/
month for the Tanzanian government. As the estimated
RDT-diagnosed prevalence of malaria in this study was
14%, RDT introduction is recommended given WHO
findings that RDTs are predicted to be cost-effective in
prevalence areas of less than 20% [21].
The findings of malaria over-diagnosis in this study
are consistent with past studies that have found that, be-
cause clinicians often perceive routine microscopy as
unreliable, with the exception of tests done on children
in high malaria transmission areas, most adults and chil-
dren treated for malaria at almost every malaria trans-
mission level show no evidence of parasites on carefully
examined research slides [22,23]. Of course, the accuracy
Figure 2 Apparent and true prevalence of malaria at the private clinic in Mwaya.
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of the RDT should also be considered – while used as
the gold standard in this study, no RDT is 100% sensitive
and specific. In this particular study, there were two in-
stances where the RDT result was negative but the mi-
croscopy was positive. Further testing of this particular
RDT in the Kilombero Valley would help elucidate the
exact efficacy of this RDT in this region.
Policy recommendations
In April 2012, WHO launched the “T3: Test. Treat.
Track.” Initiative, which urges countries to scale up diag-
nostic testing, provide quality-assured treatment, and
follow-up surveillance for malaria [24]. Both for malaria
control reasons and because ACT is expensive, it is im-
portant to target the population truly infected with mal-
aria. RDTs are a cost-effective, highly sensitive and
specific test in recognizing P. falciparum. Some RDTs,
including the ICT Combo Cassette Test used in this
study, have the capacity to detect other Plasmodium
species, but these are more expensive. Therefore, under-
standing which species of malaria exist in specific areas
can enable the selection of the proper RDT to maximize
cost-effectiveness. In the case of the Kilombero Valley,
where only P. falciparum has been detected, the intro-
duction of a P. falciparum-only RDT would result in
even greater savings. Implementing a policy aimed at de-
creasing the current over-diagnosis of malaria in the
Kilombero Valley and follow-up monitoring cases would
certainly improve the quality of life of people living in
this malaria-endemic region.
According to the World Malaria Report of 2011, with
current prices of RDTs and ACT, and perfect compli-
ance with test results, savings resulting from not over-
prescribing ACT could amount to $68 million (USD) in
the public sector in the WHO African Region [1]. If a
policy introducing RDTs to all clinics (public and pri-
vate) was implemented to increase the reliability of diag-
nostic testing of febrile patients, and quality assurance
measures were in place to ensure that both the public
and the private sectors would abide by the policy, sav-
ings would likely be even greater. This is consistent with
previous studies that have found public and private sec-
tors are important complementary sources of malaria
treatment in rural Tanzania [25]. If the government was
able to provide universal RDTs to both the private and
public sector, and if the government was able to better
regulate the distribution, prescription, and sale of anti-
malarial drugs, savings and improved care for all febrile
patients in malaria-endemic areas would follow.
In November 2012, the Global Fund Board approved
the integration of the AMFm into core global fund
grants to continue subsidizing ACT [26]. While it is very
important that quality ACT is available for proper treat-
ment of febrile cases attributed to malaria, if reliable
Figure 3 Scatter plot of RDT (blue) and microscopy (green)
prevalence in the public health centre (top) and private
dispensary (bottom). In the public health centre, either RDTs or
microscopy was used to diagnose malaria. In the private dispensary,
both RDTs and microscopy were performed on the same patient.
The sizes of the circles represent the total number of patients, in
that particular age category, who were tested.
Table 3 Prices and frequency of anti-malarial treatments
purchased at the pharmacy connected to the private
clinic
Medication Frequency (%) Price (USD)
ALu 81% Age: 0-3: 0.31
4-8: 0.63
9-14: 0.94
15+: 1.26
Metakelfin 13% 1.89
Quinine 5% 3.78
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diagnostic methods are not in place, it is difficult to en-
sure that only those patients who actually have malaria
receive ACT. Therefore, keeping in mind the WHO “T3.
Test. Treat. Track.” initiative, if some funds from the
AMFm subsidy on ACT were shifted to subsidizing
RDTs, patients would receive accurate diagnoses and as
a result, less ACT would be needed.
Conclusions
This study showed that malaria is being over-diagnosed
by 64% with microscopy in this rural region of the
United Republic of Tanzania. Due to ongoing concerns
regarding drug resistance to anti-malarial treatments, it
is important that only patients who test positive for
malaria use anti-malarial drugs. RDTs are accurate
parasitological-based tests that provide a reliable option
for malaria diagnosis in resource-limited areas. If clini-
cians properly use and act upon the results of RDTs, the
introduction of RDTs to health facilities in Tanzania
would be extremely cost-efficient. A policy dictating that
private and public clinics work together and stay dedi-
cated to properly diagnosing patients using RDTs, in
conjunction with AMFm continuing to subsidize the
costs of anti-malarials, will decrease the likelihood of
drug resistance and result in proper treatment of non-
malarial febrile illnesses.
Additional file
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